Treatment of Oral Mucositis Using Platelet-Rich-Fibrin: A Retrospective Study on Oncological Patients

J Craniofac Surg. 2023 Jul-Aug;34(5):1527-1529. doi: 10.1097/SCS.0000000000009450. Epub 2023 Jun 5.

Abstract

Oral mucositis is an inflammatory mucosal demolition frequently observed during treatments for neoplastic diseases such as chemotherapy or radiation therapy. The side effects of these treatments often drastically reduce patients' quality of life. Oral mucositis is the result of the systemic consequences of chemotherapy and radiotherapy, which due to their cytotoxic and local effects, lead to pain and severe ulceration with a consequent decrease in the quality of life of affected subjects. Plasma rich in fibrin is often used to enhance soft tissue wound healing and fight bacterial sepsis through the presence of leukocytes within it. The retrospective study aimed to evaluate the efficacy and safety of the topic use of platelet gel in the clinical management of oral mucositis to improve the life quality of patients. The results of the study were promising even though the topical application of platelet-rich-fibrin is like a skin-care treatment. Future studies with a larger sample of patients will be needed to understand the real benefits of platelet-rich-fibrin.

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Humans
  • Platelet-Rich Fibrin*
  • Quality of Life
  • Retrospective Studies
  • Stomatitis* / chemically induced
  • Stomatitis* / therapy

Substances

  • Antineoplastic Agents